Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.93
-0.19 (-1.45%)
At close: Dec 5, 2025, 4:00 PM EST
12.93
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Astria Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.71 | - | - | - | - | - | |
| Gross Profit | 0.71 | - | - | - | - | - | |
| Selling, General & Admin | 40.08 | 35.25 | 26.03 | 19.73 | 15.15 | 12.36 | |
| Research & Development | 97.14 | 76.31 | 41.8 | 33.78 | 15.21 | 25.08 | |
| Operating Expenses | 137.22 | 111.56 | 67.83 | 53.5 | 30.36 | 37.44 | |
| Operating Income | -136.51 | -111.56 | -67.83 | -53.5 | -30.36 | -37.44 | |
| Interest & Investment Income | 12.69 | 17.36 | 10.2 | 1.72 | 0.12 | 0.24 | |
| Other Non Operating Income (Expenses) | -0.21 | -0.06 | -0.06 | -0.06 | -0.06 | -0.1 | |
| EBT Excluding Unusual Items | -124.03 | -94.26 | -57.69 | -51.83 | -30.3 | -37.3 | |
| Pretax Income | -124.03 | -94.26 | -72.89 | -51.83 | -194.91 | -37.3 | |
| Net Income | -124.03 | -94.26 | -72.89 | -51.83 | -194.91 | -37.3 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 24.44 | - | |
| Net Income to Common | -124.03 | -94.26 | -72.89 | -51.83 | -219.35 | -37.3 | |
| Shares Outstanding (Basic) | 58 | 56 | 30 | 15 | 9 | 3 | |
| Shares Outstanding (Diluted) | 58 | 56 | 30 | 15 | 9 | 3 | |
| Shares Change (YoY) | 14.24% | 86.44% | 106.03% | 63.81% | 191.81% | 63.87% | |
| EPS (Basic) | -2.14 | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | |
| EPS (Diluted) | -2.14 | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | |
| Free Cash Flow | -120.32 | -81.54 | -68.47 | -43.62 | -30.17 | -32.52 | |
| Free Cash Flow Per Share | -2.07 | -1.45 | -2.27 | -2.98 | -3.38 | -10.63 | |
| Gross Margin | 100.00% | - | - | - | - | - | |
| Operating Margin | -19335.69% | - | - | - | - | - | |
| Profit Margin | -17567.99% | - | - | - | - | - | |
| Free Cash Flow Margin | -17042.92% | - | - | - | - | - | |
| EBITDA | - | - | - | - | - | -37.41 | |
| D&A For EBITDA | - | - | - | - | - | 0.03 | |
| EBIT | -136.51 | -111.56 | -67.83 | -53.5 | -30.36 | -37.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.